[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
|
[2] |
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin, 2016, 66(4):271-289.
|
[3] |
中华医学会数字医学分会, 中华医学会外科学分会胆道外科学组, 中国研究型医院学会数字医学临床外科专业委员会. 胆囊癌三维可视化诊治专家共识(2018版)[J]. 中国实用外科杂志, 2018, 38(12):1339-1346.
|
[4] |
中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断与治疗指南(2013版)[J]. 中华外科杂志, 2013, 51(10):865-871.
|
[5] |
王伟, 王坚. 围肝门外科技术治疗侵犯肝门胆囊癌的策略[J]. 中国实用外科杂志, 2019, 39(2):130-134.
|
[6] |
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58(4):243-251.
|
[7] |
Köhn N, Maubach J, Warschkow R, et al. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis[J]. HPB, 2018, 20(11):1073-1081.
|
[8] |
Lim CS, Jang JY, Lee SE, et al. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer[J].J Gastrointest Surg, 2012, 16(5):1012-1018.
|
[9] |
Sakamoto Y, Nara S, Kishi Y, et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?[J]. Surgery, 2013, 153(6):794-800.
|
[10] |
Fukami Y, Kaneoka Y, Maeda A, et al. Major hepatopancreatoduodenectomy with simultaneous resection of the hepatic artery for advanced biliary cancer[J]. Langenbecks Arch Surg, 2016, 401(4):471-478.
|
[11] |
Fernandes Ede S, Mello FT, Ribeiro-Filho J, et al. The largest Western experience with hepatopancreatoduodenectomy: lessons learned with 35 cases[J]. Arq Bras Cir Dig, 2016, 29(1):17-20.
|
[12] |
Yamamoto Y, Sugiura T, Okamura Y, et al. Is combined pancreatoduodenectomy for advanced gallbladder cancer justified?[J]. Surgery, 2016, 159(3):810-820.
|
[13] |
Dai WC, Chok KS, Cheung TT, et al. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(4):382-386.
|
[14] |
Aoki T, Sakamoto Y, Kohno Y, et al. Hepatopancreaticoduodenectomy for biliary cancer: strategies for near-zero operative mortality and acceptable long-term outcome[J]. Ann Surg, 2018, 267(2):332-337.
|
[15] |
Lee EC, Han SS, Lee SD, et al. Is Hepatopancreatoduodenectomy an acceptable operation for biliary cancer?[J]. Am Surg, 2018, 84(5): 703-711.
|
[16] |
Mizuno T, Ebata T, Yokoyama Y, et al. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer[J]. Br J Surg, 2019, 106(5):626-635.
|
[17] |
D'Souza MA, Valdimarsson VT, Campagnaro T, et al. Hepatopancreatoduodenectomy-a controversial treatment for bile duct and gallbladder cancer from a European perspective[J]. HPB, 2020, 22(9):1339-1348.
|
[18] |
Kuipers H, de Savornin Lohman EAJ, van Dooren M, et al. Extended resections for advanced gallbladder cancer: results from a nationwide cohort study[J]. Ann Surg Oncol, 2021, 28(2):835-843.
|
[19] |
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 围肝门区域外科技术临床应用路径中国专家共识(2020版)[J]. 中国实用外科杂志, 2020, 40(6):26-34.
|
[20] |
Berger-Richardson D, Chesney TR, Englesakis M, et al. Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: a systematic review[J]. Surgery, 2017, 161(3):618-627.
|
[21] |
Gumbs AA, Hoffman JP. Laparoscopic completion radical cholecystectomy for T2 gallbladder cancer[J]. Surg Endosc, 2010, 24(12):3221-3223.
|
[22] |
Shirobe T, Maruyama S. Laparoscopic radical cholecystectomy with lymph node dissection for gallbladder carcinoma[J]. Surg Endosc, 2015, 29(8):2244-2250.
|
[23] |
Machado MA, Makdissi FF, Surjan RC. Totally laparoscopic hepatic bisegmentectomy (s4b+s5) and hilar lymphadenectomy for incidental gallbladder cancer[J]. Ann Surg Oncol, 2015, 22 Suppl 3:S336-339.
|
[24] |
Palanisamy S, Patel N, Sabnis S, et al. Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention[J]. Surg Endosc, 2016, 30(6):2442-2448.
|
[25] |
Ome Y, Hashida K, Yokota M, et al. Laparoscopic approach to suspected T1 and T2 gallbladder carcinoma[J]. World J Gastroenterol, 2017, 23(14):2556-2565.
|
[26] |
张铃福, 侯纯升, 徐智, 等. T2期胆囊癌腹腔镜胆囊切除术及根治术的可行性分析[J]. 中华普通外科杂志, 2017, 32(5):389-392.
|
[27] |
Castro CM, Santibañez SP, Rivas TC, et al. Totally laparoscopic radical resection of gallbladder cancer: technical aspects and long-term results[J]. World J Surg, 2018, 42(8):2592-2598.
|
[28] |
Kim S, Yoon YS, Han HS, et al. Laparoscopic extended cholecystectomy for T3 gallbladder cancer[J]. Surg Endosc, 2018, 32(6):2984-2985.
|
[29] |
张德智, 刘现立, 赵玉鹏. 完全腹腔镜根治术治疗胆囊癌患者安全性及疗效临床分析[J]. 实用肝脏病杂志, 2018, 21(4):529-532.
|
[30] |
Parasar K, Saluja SS, Varshney VK, et al. Early recurrence after laparoscopic radical cholecystectomy in a patient with gallbladder cancer[J]. J Minim Access Surg, 2019, 15(1):74-76.
|
[31] |
潘德标, 叶冠雄, 徐胜前, 等. 腹腔镜根治术与开腹根治术治疗早期胆囊癌的临床疗效比较[J]. 肝胆胰外科杂志, 2019, 31(2): 83-86.
|
[32] |
杨威, 金丹. 腹腔镜胆囊癌根治术治疗仅侵犯胆囊黏膜或黏膜固有层胆囊癌的效果及远期预后研究[J]. 中国内镜杂志, 2020, 26(10):68-73.
|
[33] |
王伟, 别玉坤, 尹余余. 腹腔镜下胆囊癌根治术的有效性及安全性研究[J]. 实用癌症杂志, 2020, 35(4):609-611, 642.
|
[34] |
Nag HH, Sachan A, Nekarakanti PK. Laparoscopic versus open extended cholecystectomy with bi-segmentectomy (s4b and s5) in patients with gallbladder cancer[J]. J Minim Access Surg, 2021, 17(1):21-27.
|
[35] |
Regmi P, Hu HJ, Chang-Hao Y, et al. Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China[J]. Surg Endosc, 2021, 35(12):6505-6512.
|
[36] |
D'Silva M, Han HS, Yoon YS, et al. Comparative study of laparoscopic versus open liver resection in gallbladder cancer[J]. J Laparoendosc Adv Surg Tech A, 2022, 32(8):854-859.
|
[37] |
韩伟光, 莘玮. 腹腔镜与开腹胆囊癌根治术治疗早期胆囊癌的临床研究[J]. 中国肿瘤临床与康复, 2021, 28(10):1153-1157.
|
[38] |
阮一, 王逻逻, 卢叶挺,等. 完全腹腔镜胆囊癌根治术治疗胆囊癌的单中心经验分析[J]. 现代实用医学, 2021, 33(12):1576-1578.
|
[39] |
Dou C, Zhang C, Zhang C, et al. Propensity score analysis of outcomes following laparoscopic or open radical resection for gallbladder cancer in T2 and T3 stages[J]. J Gastrointest Surg, 2022, 26(7):1416-1424.
|
[40] |
Shimizu H, Kimura F, Yoshidome H, et al. Aggressive surgical approach for stageⅣgallbladder carcinoma based on Japanese Society of Biliary Surgery classification[J]. J Hepatobiliary Pancreat Surg, 2007, 14(4):358-365.
|